ZIG
GILD icon

Zullo Investment Group’s Gilead Sciences GILD Stock Holding History

Zullo Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-687
Closed -$59K – 365
2022
Q4 		$59K Buy
687
+28
+4% +$2.22K 0.04% 258
2022
Q3 		$41K Buy
659
+34
+5% +$2.14K 0.03% 293
2022
Q2 		$39K Buy
625
+149
+31% +$9.22K 0.02% 308
2022
Q1 		$28K Buy
476
+453
+1,970% +$29K 0.01% 380
2021
Q4 		$2K Buy
+23
New +$1.58K ﹤0.01% 757

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zullo Investment Group's GILD Position: Q1 2023 in Review

Zullo Investment Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 687 shares — an estimated $59K sold.

Zullo Investment Group first reported a position in GILD in Q4 2021 and held it in 5 quarters. The position peaked at $59K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Zullo Investment Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 687 Gilead Sciences shares in Q1 2023, an estimated $59K.
  • Zullo Investment Group first reported a position in Gilead Sciences in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Gilead Sciences position peaked at $59K in Q4 2022.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.